EUVIMEDEUVIMED entdecken
Fallbericht

A family with neuronal intranuclear inclusion disease with focal segmental glomerulosclerosis

Kazuki Watanabe, Tomoyasu Bunai, Masamune Sakamoto, Sayaka Ishigaki, Takamasa Iwakura, Naro Ohashi, Rie Wakatsuki, Akiyuki Takenouchi, Moriya Iwaizumi, Yoshihiro Hotta, Ken Saida, Eriko Koshimizu und 4 weitere

Journal of Neurology · 2024

DOI: 10.1007/s00415-024-12593-w ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Neurology, 2024. Verfasst von Kazuki Watanabe und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Hamamatsu University School of Medicine, 1-20-1 Handayama, Chuo-Ku, Hamamatsu, 431-3192, Japan. Hauptthemen laut MEDLINE: Glomerulosclerosis, Focal Segmental, Intranuclear Inclusion Bodies, Neurodegenerative Diseases, Pedigree. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science, Japan Research Promotion Society for Cardiovascular Diseases, Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Neuronal intranuclear inclusion disease (NIID) is a rare neurodegenerative disease caused by the expansion of GGC repeats in the 5'-untranslated region (5'-UTR) of NOTCH2NLC. Although increasing evidence suggests that NIID affects various organs, its association with renal involvement remains unclear. We studied the genetic background of a family with NIID, in which four of five members presented with proteinuria as the initial manifestation. The renal pathology of three patients was diagnosed as focal segmental glomerulosclerosis (FSGS) at a previous hospital. These patients also presented with tremors, retinal degeneration, and episodic neurological events. Finally, one patient exhibited reversible bilateral thalamic high-intensity signal changes on diffusion-weighted imaging during episodic neurological events. METHODS: Exome sequencing (ES) and nanopore long-read whole-genome sequencing (LR-WGS) were performed on the index case, followed by nanopore target sequencing using Cas9-mediated PCR-free enrichment and methylation analysis. RESULTS: ES revealed no candidate variants; however, nanopore LR-WGS in the index case revealed expansion of short tandem repeats (STR) in NOTCH2NLC. Subsequent nanopore target sequencing using Cas9-mediated PCR-free enrichment showed STR expansion of NOTCH2NLC in an affected sibling and asymptomatic father. Methylation analysis using nanopore data revealed hypermethylation of the expanded allele in the asymptomatic father and partial hypermethylation in a mildly symptomatic sibling, whereas the expanded allele was hypomethylated in the index case. CONCLUSIONS: This investigation expands the clinical spectrum of NIID, suggesting that STR expansion of NOTCH2NLC is a cause of renal diseases, including FSGS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glomerulosclerosis, Focal SegmentalIntranuclear Inclusion BodiesNeurodegenerative DiseasesPedigreeHumansMaleFemaleAdultReceptor, Notch2Middle Aged

Stichwörter der Autor:innen

Focal segmental glomerulosclerosisHypermethylationNanopore long-read sequencingNeuronal intranuclear inclusion diseaseThalamus

Substanzen

Receptor, Notch2NOTCH2 protein, human

Autor:innen und Institutionen

  • Department of Neurology, Hamamatsu University School of Medicine, 1-20-1 Handayama, Chuo-Ku, Hamamatsu, 431-3192, Japan.
  • Department of Biochemistry, Hamamatsu University School of Medicine, 1-20-1 Handayama, Chuo-Ku, Hamamatsu, 431-3192, Japan.
  • Department of Human Genetics, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-Ku, Yokohama, 236-0004, Japan.
  • Department of Rare Disease Genomics, Yokohama City University Hospital, 3-9 Fukuura, Kanazawa-Ku, Yokohama, 236-0004, Japan.
  • Department of Nephrology, Hamamatsu University School of Medicine, 1-20-1 Handayama, Chuo-Ku, Hamamatsu, 431-3192, Japan.
  • Department of Laboratory Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Chuo-Ku, Hamamatsu, Shizuoka, 431-3125, Japan.

Förderung

  • Japan Society for the Promotion of Science
  • Japan Research Promotion Society for Cardiovascular Diseases
  • Japan Agency for Medical Research and Development
  • Takeda Science Foundation

Zitieren

APA

Watanabe, K., Bunai, T., Sakamoto, M., Ishigaki, S., Iwakura, T., Ohashi, N., Wakatsuki, R., Takenouchi, A., Iwaizumi, M., Hotta, Y., Saida, K., Koshimizu, E., Miyatake, S., Saitsu, H., Matsumoto, N., & Nakamura, T. (2024). A family with neuronal intranuclear inclusion disease with focal segmental glomerulosclerosis. Journal of Neurology. https://doi.org/10.1007/s00415-024-12593-w

Vancouver

Watanabe K, Bunai T, Sakamoto M, Ishigaki S, Iwakura T, Ohashi N, et al. A family with neuronal intranuclear inclusion disease with focal segmental glomerulosclerosis. Journal of Neurology. 2024. doi:10.1007/s00415-024-12593-w

BibTeX
@article{Watanabe2024,
  author = {Watanabe, Kazuki and Bunai, Tomoyasu and Sakamoto, Masamune and Ishigaki, Sayaka and Iwakura, Takamasa and Ohashi, Naro and Wakatsuki, Rie and Takenouchi, Akiyuki and Iwaizumi, Moriya and Hotta, Yoshihiro and Saida, Ken and Koshimizu, Eriko and Miyatake, Satoko and Saitsu, Hirotomo and Matsumoto, Naomichi and Nakamura, Tomohiko},
  title = {A family with neuronal intranuclear inclusion disease with focal segmental glomerulosclerosis},
  journal = {Journal of Neurology},
  year = {2024},
  doi = {10.1007/s00415-024-12593-w}
}
Kostenlos starten →